7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Parkinsonian Disorders in 2 studies
7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Kampen, JM | 1 |
| Eckman, CB | 1 |
| Sánchez-Pernaute, R | 1 |
| Jenkins, BG | 1 |
| Choi, JK | 1 |
| Iris Chen, YC | 1 |
| Isacson, O | 1 |
2 other studies available for 7-hydroxy-2-n,n-dipropylaminotetralin and Parkinsonian Disorders
| Article | Year |
|---|---|
Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior.
Topics: Animals; Cell Division; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Female; Motor Ac | 2006 |
In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias.
Topics: Animals; Brain; Cerebrovascular Circulation; Dopamine Agents; Dyskinesia, Drug-Induced; Levodopa; Ma | 2007 |